KAMADA

Kamada is a global biopharmaceutical company with a portfolio of products indicated for rare and serious conditions and a leader in specialty-plasma therapies.

[KAMADA @Kamada_Pharma]

Kamada is joining the international respiratory community at the European Respiratory Society (ERS) Congress in Barcelona.

We look forward to exchanging knowledge & connecting with healthcare professionals & partners to discuss developments in respiratory medicine & patient care

[KAMADA @Kamada_Pharma]

August is National Multiethnic Donor Awareness Month. More than 109,000 people in the U.S. await an organ transplant, nearly 60% are from racial and ethnic minority communities. At Kamada, we support transplant patients and raise awareness. Learn more 🔗https://t.co/uVKuiGhH30

[KAMADA @Kamada_Pharma]

Happy New Year! 🎉
Wishing our partners, colleagues, and friends a healthy, successful 2026.
Thank you for your trust and collaboration. We look forward to another year of shared growth and innovation in healthcare.

[KAMADA @Kamada_Pharma]

On #IDPWD, we honor the 1B+ people living with disabilities and reaffirm our commitment to a workplace built on respect, inclusion, and equal opportunity for all.

[KAMADA @Kamada_Pharma]

Our long-term commitment to Alpha-1 means partnering with the community, driving awareness, supporting research, and delivering high-quality augmentation therapy.

[KAMADA @Kamada_Pharma]

Alpha-1 Antitrypsin Deficiency is still underdiagnosed. For patients with lung involvement, plasma-derived augmentation therapy can help slow progression. Learn more at: https://t.co/9lrgxucqE4

[KAMADA @Kamada_Pharma]

SHIELD is a new prospective study evaluating CYTOGAM to help prevent late CMV in high-risk kidney transplant recipients. This investigator-initiated trial is supported by @Kamada_Pharma. Learn more: https://t.co/vyNqvwKH7I

[KAMADA @Kamada_Pharma]

Still thinking it’s asthma or COPD? It could be Alpha-1! This Awareness Month, @Kamada_Pharma reinforces its commitment to expanding awareness and supporting patients worldwide.

[KAMADA @Kamada_Pharma]

This #PlasmaAwarenessWeek, @Kamada_Pharma joins the Plasma Protein Therapeutics Association (PPTA) in highlighting plasma donation and plasma-derived medicines.

[KAMADA @Kamada_Pharma]

Proud to join the ERS International Congress this week in Amsterdam, advancing lung disease care with clinicians, partners & advocates worldwide. #ERSCongress #LungHealth

[KAMADA @Kamada_Pharma]

On #WorldRabiesDay we remind: rabies kills thousands, but rapid post-exposure care saves lives. For over 20 years @Kamada_Pharma has helped deliver this vital protection worldwide.

[KAMADA @Kamada_Pharma]

People with ITP have low platelet count, leading to easy bruising, bleeding, and sometimes more serious internal bleeding.

This ITP Awareness Week, we stand with the community to raise awareness and reinforce the importance of education and access to care.

[KAMADA @Kamada_Pharma]

@ISHLT

Now on the @ISHLT (The International Society for Heart and Lung Transplantation website): CMV Stream 2025 - Highlights for transplant teams from the new CMV guidelines and expert Q&A.

https://t.co/WnAPafkP5Q

[The ISHLT @ISHLT]

👉 Check out CMV Stream 2025 by #Kamada, which is now available on-demand. Leading voices in #transplantation addressed the latest updates, key challenges, and evolving strategies in #CMV management and prevention.💡📽️ Watch now at 🔗: https://t.co/Dp3sXwrSY7

[KAMADA @Kamada_Pharma]

Our new plasma collection center in Houston has FDA approval and is ready for commercial sales. Read more: https://t.co/D3dKIpiqfd

[KAMADA @Kamada_Pharma]

Proud to have been part of World Transplant Congress 2025, where we connected with colleagues, learned the latest, and worked together to advance care for the transplant patient community.

[KAMADA @Kamada_Pharma]

60% of those on the U.S. transplant waitlist are from communities of color. During #MinorityDonorAwarenessMonth, we stand for equity and honor the donors offering second chances.

[KAMADA @Kamada_Pharma]

Every 30 seconds, someone dies from hepatitis. Yet every death is preventable. At @Kamada_Pharma, we support awareness and prevention efforts, especially around HBV.

[KAMADA @Kamada_Pharma]

Excited to exhibit at #WTC2025 in San Francisco!
Meet us at Booth #430 to explore our hyperimmune solutions for transplant patients!
See you there!
🔗 https://t.co/WZQik4w2Te

[KAMADA @Kamada_Pharma]

Happy 4th of July from @Kamada_Pharma !
Proud to support U.S. patients & providers with trusted therapies.
Wishing our teams & friends a joyful Independence Day! 🎆🇺🇸